Question

Will bimagrumab be approved for the treatment of obesity by the FDA or EMA by 2029?

1 comment1

Total Forecasters21

Community Prediction32.6% (22.6% - 33%)

Make a Prediction

50%

community: 32.6%

Authors:

casens

Opened:

Nov 24, 2021

Closes:

Dec 5, 2025

Scheduled resolution:

Jan 1, 2029

Health & Pandemics

2021-2025 Leaderboard

Food and Drug Administration

Weight loss drug Wegovy approved to treat heart disease in overweight and obese Australian patients

Guardian•Feb 18, 2025

The next battle in the weight-loss drug war is focussed on muscle growth

Independent•Feb 20, 2025

New weight loss drugs aim to promote muscle growth

New York Post•Feb 20, 2025

Learn more about Metaculus NewsMatch

Will the combination of semaglutide and cagrilintide be approved for the treatment of obesity by the FDA or EMA by 2027?

43%

Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?

80.8%

Will a small molecule GLP-1-based drug be approved for the treatment of obesity by the FDA or EMA by 2029?

59.7%

Comments

? comments